These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 27114745)

  • 1. Human induced pluripotent stem cells for monogenic disease modelling and therapy.
    Spitalieri P; Talarico VR; Murdocca M; Novelli G; Sangiuolo F
    World J Stem Cells; 2016 Apr; 8(4):118-35. PubMed ID: 27114745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New frontier in regenerative medicine: site-specific gene correction in patient-specific induced pluripotent stem cells.
    Garate Z; Davis BR; Quintana-Bustamante O; Segovia JC
    Hum Gene Ther; 2013 Jun; 24(6):571-83. PubMed ID: 23675640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Human Induced Pluripotent Stem Cells from Extraembryonic Tissues of Fetuses Affected by Monogenic Diseases.
    Spitalieri P; Talarico RV; Botta A; Murdocca M; D'Apice MR; Orlandi A; Giardina E; Santoro M; Brancati F; Novelli G; Sangiuolo F
    Cell Reprogram; 2015 Aug; 17(4):275-87. PubMed ID: 26474030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Mucosa-Derived Induced Pluripotent Stem Cells from Patients with Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome.
    Trevisan M; Alvisi G; Barbaro V; Barzon L; Raffa P; Migliorati A; Desole G; Ruzittu S; Masi G; Di Iorio E; Palù G
    Cell Reprogram; 2018 Aug; 20(4):215-224. PubMed ID: 29989433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies.
    Pratumkaew P; Issaragrisil S; Luanpitpong S
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
    Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
    Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
    Meneghini V; Frati G; Sala D; De Cicco S; Luciani M; Cavazzin C; Paulis M; Mentzen W; Morena F; Giannelli S; Sanvito F; Villa A; Bulfone A; Broccoli V; Martino S; Gritti A
    Stem Cells Transl Med; 2017 Feb; 6(2):352-368. PubMed ID: 28191778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise Review; The Recent Methods that Enhance the Osteogenic Differentiation of Human Induced Pluripotent Stem Cells.
    Hou Y; Yan Z; Wu Z
    Curr Stem Cell Res Ther; 2021; 16(8):949-957. PubMed ID: 33563178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation dynamics in human induced pluripotent stem cells.
    Nishino K; Umezawa A
    Hum Cell; 2016 Jul; 29(3):97-100. PubMed ID: 27083573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
    Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
    Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine.
    Walia B; Satija N; Tripathi RP; Gangenahalli GU
    Stem Cell Rev Rep; 2012 Mar; 8(1):100-15. PubMed ID: 21671061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective.
    Dalvi S; Galloway CA; Singh R
    Adv Exp Med Biol; 2019; 1186():1-31. PubMed ID: 31654384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human induced pluripotent stem cell and nanotechnology-based therapeutics.
    Liu WH; Chang YL; Lo WL; Li HY; Hsiao CW; Peng CH; Chiou SH; Ma HI; Chen SJ
    Cell Transplant; 2015; 24(11):2185-95. PubMed ID: 25299513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profile in human induced pluripotent stem cells: Chondrogenic differentiation in vitro, part A.
    Suchorska WM; Augustyniak E; Richter M; Trzeciak T
    Mol Med Rep; 2017 May; 15(5):2387-2401. PubMed ID: 28447755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age Is Relative-Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality.
    Strässler ET; Aalto-Setälä K; Kiamehr M; Landmesser U; Kränkel N
    Front Cardiovasc Med; 2018; 5():4. PubMed ID: 29423397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the potential of poly(beta-amino ester) nanoparticles for reprogramming human fibroblasts to become induced pluripotent stem cells.
    Bhise NS; Wahlin KJ; Zack DJ; Green JJ
    Int J Nanomedicine; 2013; 8():4641-58. PubMed ID: 24348039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Four Protocols to Generate Chondrocyte-Like Cells from Human Induced Pluripotent Stem Cells (hiPSCs).
    Suchorska WM; Augustyniak E; Richter M; Trzeciak T
    Stem Cell Rev Rep; 2017 Apr; 13(2):299-308. PubMed ID: 27987073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient characteristics of universal cells on human-induced pluripotent stem cells and their differentiated cells derived from foetal stem cells with mixed donor sources.
    Sung TC; Jiang YP; Hsu JY; Ling QD; Chen H; Kumar SS; Chang Y; Hsu ST; Ye Q; Higuchi A
    Cell Prolif; 2021 Mar; 54(3):e12995. PubMed ID: 33522648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.